Figure 2.
Comparison of targeted sequencing using DNA from plasma or FFPE lymph node sections. (A) Plots compare amounts of mutation in plasma (human genome equivalents [hGE]) with VAF (%) in lymph node from FFPE tissue. Results are presented for 9 individual cases together with a combined plot of all patients. Individual RHOA mutations and other detected and mutated genes are color coded as shown. (B) Four cores were sequenced from a single lymph node. Results of the sequencing are indicated in the table with a color scale being used to indicate the VAF. Middle panel shows a hematoxylin and eosin–stained lymph node section indicating the positions of cores labeled C1 to C4. Right panel shows immunofluorescence staining of a sequential lymph node section to show heterogeneity of CD4 staining.

Comparison of targeted sequencing using DNA from plasma or FFPE lymph node sections. (A) Plots compare amounts of mutation in plasma (human genome equivalents [hGE]) with VAF (%) in lymph node from FFPE tissue. Results are presented for 9 individual cases together with a combined plot of all patients. Individual RHOA mutations and other detected and mutated genes are color coded as shown. (B) Four cores were sequenced from a single lymph node. Results of the sequencing are indicated in the table with a color scale being used to indicate the VAF. Middle panel shows a hematoxylin and eosin–stained lymph node section indicating the positions of cores labeled C1 to C4. Right panel shows immunofluorescence staining of a sequential lymph node section to show heterogeneity of CD4 staining.

Close Modal

or Create an Account

Close Modal
Close Modal